Pure Global

Efficacy and safety of fosravuconazole for the treatment of onychomycosis: A multicenter, retrospective study - Trial UMIN000045924

Access comprehensive clinical trial information for UMIN000045924 through Pure Global AI's free database. This Not Applicable trial is sponsored by Sato Pharmaceutical Co.,Ltd and is currently Completed. The study focuses on Onychomycosis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000045924
Not Applicable
Completed
Trial Details
University Hospital Medical Information Network โ€ข UMIN000045924
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy and safety of fosravuconazole for the treatment of onychomycosis: A multicenter, retrospective study

Study Focus

Onychomycosis

Observational

Sponsor & Location

Sato Pharmaceutical Co.,Ltd

Japan

Timeline & Enrollment

Not Applicable

Nov 01, 2021

N/A

ICD-10 Classifications

Onychogryphosis
Chromomycosis, unspecified
Onycholysis
Actinomycosis
Blastomycosis

Data Source

University Hospital Medical Information Network

UMIN000045924

Non-Device Trial